Vitamin b12 and Kynmobi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vitamin b12 (cobalamin) and Kynmobi (apomorphine hydrochloride). Common drug interactions include urinary tract infection among females and gait disturbance among males.

The phase IV clinical study analyzes what interactions people have when they take Vitamin b12 and Kynmobi. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Vitamin b12?

Vitamin b12 has active ingredients of cobalamin. It is often used in vitamin b12 deficiency. eHealthMe is studying from 121,681 Vitamin b12 users. Check the latest studies of Vitamin b12.

What is Kynmobi?

Kynmobi has active ingredients of apomorphine hydrochloride. eHealthMe is studying from 2,384 Kynmobi users. Check the latest studies of Kynmobi.



On Jul, 21, 2026

11 people who take Vitamin b12 and Kynmobi together, and have interactions are studied.

Vitamin b12 and Kynmobi drug interactions.

What are the common drug interactions of Vitamin B12 and Kynmobi, by gender? *:

female:

  1. Urinary tract infection
  2. Abdominal discomfort
  3. Multiple fractures
  4. Rib fracture
  5. Somnolence (a state of near-sleep, a strong desire for sleep)
  6. Tremor (trembling or shaking movements in one or more parts of your body)
  7. Abdominal pain upper
  8. Adverse event
  9. Blood pressure increased
  10. Chest discomfort

male:

  1. Gait disturbance
  2. Spinal cord injury
  3. Spinal stenosis (narrowing of spinal column)

What are the common drug interactions of Vitamin B12 and Kynmobi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Nonspecific reaction (unspecified reaction)
  2. Vomiting
  3. Abdominal pain upper
  4. Adverse event
  5. Blood pressure increased
  6. Chest discomfort
  7. Choking (mechanical obstruction of the flow of air from the environment into the lungs)
  8. Cough
  9. Depression
  10. Diarrhoea

What are the existing conditions these people have? *

  1. Parkinson's Disease: 11 people, 100.00%
  2. Movement - Uncontrolled Or Slow: 4 people, 36.36%
  3. Sleep Disorder: 2 people, 18.18%
  4. Depression: 2 people, 18.18%
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 18.18%
  6. On And Off Phenomenon: 1 person, 9.09%
  7. Dyskinesia (abnormality or impairment of voluntary movement): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Vitamin b12 and Kynmobi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vitamin b12 and Kynmobi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vitamin b12:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Kynmobi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vitamin b12 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kynmobi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cobalamin and apomorphine hydrochloride (the active ingredients of Vitamin b12 and Kynmobi, respectively), and Vitamin b12 and Kynmobi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: